Skip to main content
. 2021 Sep 9;10(9):1088. doi: 10.3390/antibiotics10091088
EI extended infusion
CI continuous infusion
STI short-term intravenous infusion
RCTs randomized controlled trials
PK pharmacokinetic
PPK population pharmacokinetic
PD pharmacodynamic
MER meropenem
MDR multi-drug resistant
MIC minimum inhibitory concentration
%fT > MIC the time at which free concentrations remain above the minimum inhibitory concentration
GRADE grading of Recommendations Assessment, Development and Evaluation approach
LOS late-onset sepsis
AEs adverse events
PTA probability of target attainment
CFR cumulative fraction of response
PRISMA the preferred reporting items for systematic review and meta-analyses
AMSTAR a measurement tool to assess systematic reviews